Inbio ventures

Latest news

Our Portfolio Company, Jounce Therapeutics, Announced Pricing of Initial Public Offering

read more →

Pharmstandard International Represented by Inbio Ventures Participated in Series B Financing of Neon Therapeutics

read more →

Pharmstandard International S.A. Represented by Inbio Ventures Leads a $20M Syndicated Series C Financing in Avelas Biosciences

read more →